Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

Lung Cancer

eISSN: 1872-8332pISSN: 0169-5002

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Aims and Scope

Lung Cancer is a peer-reviewed medical journal published by Elsevier originally published on behalf of the International Association for the Study of Lung Cancer (until 2006). As of 2015, it is published on behalf of the International Lung Cancer Consortium, the European Thoracic Oncology Platform, and the British Thoracic Oncology Group. It includes original research and review articles of relevance to lung cancer. Less

Key Metrics

CiteScore
9.4
Eigenfactor
0.01 - 0.05
H-Index
141
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.44
Time to Publish
time-to-publish View Chart
3  Mo

Journal Specifications

Overview
  • Publisher
    ELSEVIER IRELAND LTD
  • Language
    English
  • Frequency
    Monthly
General Details
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 57%
4-6 34%
7-9 8%
>9 1%

Topics Covered

Cancer
Lung cancer
Lymph node
Progression-free survival
Computed tomography
Crizotinib
Immunotherapy
Exon
Immune checkpoint inhibitors
Epidermal growth factor receptor
Chemoradiotherapy
Overall survival
Lung
Adenocarcinoma
Toxicity
Artificial intelligence
Cohort study
Central nervous system
Met amplification
Mesothelioma

Recently Published Papers

Year-wise Publication

FAQs

Since when has Lung Cancer been publishing? Faqs

The Lung Cancer has been publishing since 1985 till date.

How frequently is the Lung Cancer published? Faqs

Lung Cancer is published Monthly.

What is the H-index. SNIP score, Citescore and SJR of Lung Cancer? Faqs

Lung Cancer has a H-index score of 141, Citescore of 9.4, SNIP score of 1.44, & SJR of Q1

Who is the publisher of Lung Cancer? Faqs

The publisher of Lung Cancer is ELSEVIER IRELAND LTD.

Where can I find a journal's aims and scope of Lung Cancer? Faqs

For the Lung Cancer's Aims and Scope, please refer to the section above on the page.

How can I view the journal metrics of Lung Cancer on editage? Faqs

For the Lung Cancer metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Lung Cancer? Faqs

The eISSN number is 1872-8332 and pISSN number is 0169-5002 for Lung Cancer.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Lung cancer, Lymph node, Progression-free survival, Computed tomography, Crizotinib, Immunotherapy, Exon, Immune checkpoint inhibitors, Epidermal growth factor receptor, Chemoradiotherapy, Overall survival, Lung, Adenocarcinoma, Toxicity, Artificial intelligence, Cohort study, Central nervous system, Met amplification, Mesothelioma.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.